At one end of rectangular origami carriers, human epidermal growth factor receptor 2 (HER2) affibody molecules (Kd = 22 pmol/L) were attached for enhancing the proximity and targeting specificity of the DNA structure to HER2‐positive breast cancer cells. Here, ERBB2 is linked to breast cancer.